title: Salicylate-induced cochlear impairments, cortical hyperactivity and re-tuning, and tinnitus.
abstract: High doses of sodium salicylate (SS) have long been known to induce temporary hearing loss and tinnitus, effects attributed to cochlear dysfunction. However, our recent publications reviewed here show that SS can induce profound, permanent, and unexpected changes in the cochlea and central nervous system. Prolonged treatment with SS permanently decreased the cochlear compound action potential (CAP) amplitude in vivo. In vitro, high dose SS resulted in a permanent loss of spiral ganglion neurons and nerve fibers, but did not damage hair cells. Acute treatment with high-dose SS produced a frequency-dependent decrease in the amplitude of distortion product otoacoustic emissions and CAP. Losses were greatest at low and high frequencies, but least at the mid-frequencies (10-20 kHz), the mid-frequency band that corresponds to the tinnitus pitch measured behaviorally. In the auditory cortex, medial geniculate body and amygdala, high-dose SS enhanced sound-evoked neural responses at high stimulus levels, but it suppressed activity at low intensities and elevated response threshold. When SS was applied directly to the auditory cortex or amygdala, it only enhanced sound evoked activity, but did not elevate response threshold. Current source density analysis revealed enhanced current flow into the supragranular layer of auditory cortex following systemic SS treatment. Systemic SS treatment also altered tuning in auditory cortex and amygdala; low frequency and high frequency multiunit clusters up-shifted or down-shifted their characteristic frequency into the 10-20 kHz range thereby altering auditory cortex tonotopy and enhancing neural activity at mid-frequencies corresponding to the tinnitus pitch. These results suggest that SS-induced hyperactivity in auditory cortex originates in the central nervous system, that the amygdala potentiates these effects and that the SS-induced tonotopic shifts in auditory cortex, the putative neural correlate of tinnitus, arises from the interaction between the frequency-dependent losses in the cochlea and hyperactivity in the central nervous system.
authors.affiliation: Center for Hearing & Deafness, SUNY at Buffalo, 137 Cary Hall, Buffalo, NY 14214, USA. gchen7@buffalo.edu
authors.forename: Guang-Di
authors.initials: GD
authors.lastname: Chen
authors.forename: Daniel
authors.initials: D
authors.lastname: Stolzberg
authors.forename: Edward
authors.initials: E
authors.lastname: Lobarinas
authors.forename: Wei
authors.initials: W
authors.lastname: Sun
authors.forename: Dalian
authors.initials: D
authors.lastname: Ding
authors.forename: Richard
authors.initials: R
authors.lastname: Salvi
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000679:Amygdala / Q000187:drug effects / Q000503:physiopathology; D000818:Animals; D001303:Auditory Cortex / Q000187:drug effects / Q000503:physiopathology; D001306:Auditory Pathways / Q000187:drug effects / Q000503:physiopathology; D003051:Cochlea / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology*; D005072:Evoked Potentials, Auditory / Q000187:drug effects; D005829:Geniculate Bodies / Q000187:drug effects / Q000503:physiopathology; D017084:Otoacoustic Emissions, Spontaneous / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013216:Reflex, Startle / Q000187:drug effects; D012980:Sodium Salicylate / Q000633:toxicity*; D013136:Spiral Ganglion / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D014012:Tinnitus / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology*
chemical_list: D012980:Sodium Salicylate